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a b s t r a c t
Object: Intramedullary hemangioblastomas are rare lesions. They can be related to von
Hippel–Lindau syndrome or they may be sporadic. This study describes surgical treatment
for this infrequent tumor.
Methods: Twelve consecutive patients received surgery to remove sporadic or von Hippel–
Lindau syndrome-associated intramedullary hemangioblastomas. Patients were evaluated
at four time points: before treatment, on postoperative day one, on the day of discharge, and
at a follow-up examination.
Results: The patients showed good preoperative neurological status. The cohort had a slight
female predominance. All tumors spanned at least one spinal segment. In all cases, total
tumor removal was achieved, and a good outcome was obtained. None of the following
factors had a signiﬁcant effect on outcome: age, sex, tumor size, the presence of a syrinx, or
the presence of von Hippel–Lindau syndrome.
Conclusions: The surgical removal of intramedullary hemangioblastomas resulted in satis-
factory long-term functional outcomes. The best results were obtained before neurological
symptoms occurred. Thus, we suggest that surgery should be considered for managing
asymptomatic, surgically accessible, space-occupying lesions in sIH group, and isolated,
space-occupying lesions in vHLS-IH group.
# 2016 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Intramedullary hemangioblastomas are rare neoplasms.
They account for about 2% of all spinal cord tumors [1].* Corresponding author at: Department of Neurosurgery, Medical Univ
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Abbreviations: vHLS, von Hippel–Lindau syndrome; IH, intramedul
blastoma; mMS, modiﬁed McCormick scale.
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0028-3843/# 2016 Polish Neurological Society. Published by Elsevier SHemangioblastomas are highly vascularized tumors, and due
to their vascular permeability, they produce peritumoral cysts,
which occur in about 50% of cases [2]. About 70% of
intramedullary hemangioblastomas are isolated (sporadic,
sIH), and 30% are associated with von Hippel–Lindauersity of Warsaw, Banacha Street 1a, 02-097 Warsaw, Poland.
lary hemangioblastoma; sIH, sporadic intramedullary hemangio-
p. z o.o. All rights reserved.
Fig. 1 – C1–C3 hemangioblastoma before and after
treatment.
Fig. 2 – Th6 hemangioblastoma before and after treatment.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 3 4 9 – 3 5 5350syndrome (vHLS-IH) [3]. The rarity of these tumors has
precluded a precise deﬁnition of a detailed treatment scheme.
The natural history of these tumors is difﬁcult to deﬁne,
because they have unpredictable growth rates [4]. The aim of
this study was to evaluate the short- and long-term results of
the surgical removal of sIH and vHLS-IH, with attention to
outcome in patients with asymptomatic vHLS-associated
tumors.
2. Materials and methods
This retrospective study reviewed medical charts for 12
consecutive patients that received surgery for sporadic-IH
(n = 6) and vHLS-IH (n = 6).
2.1. Clinical evaluation
Patients were evaluated at four time points: before treatment,
on postoperative day one, on the day of discharge (early
outcome), and at a follow-up examination (late outcome). The
early and late outcomes were compared separately for patients
with sIH and vHLS-IH. Follow-up data were obtained from
medical charts, from telephone interviews with the patients,
and from interviews during individual visits. Patients were
assessed with a modiﬁed McCormick scale (mMS, Table 1) [5].
The follow-up period ranged from 3 to 10 years (average 5
years). Complete follow-up data were obtained in all cases.
2.2. Imaging evaluation
All patients underwent contrast-enhanced MRI before and
after operative treatment. Spinal angiography was performed
in eight (67%) patients.
2.3. Surgery
All tumors were removed via a posterior approach. Patients
were placed in a prone position for removing tumors located in
the thoracic spine and at the level of the atlanto-occipital
junction. Patients were placed in a sitting position for
removing tumors located in the cervical spine and at the
cervico-thoracic junction. Three patients received laminec-
tomies with an extended suboccipital craniotomy. Surgery was
initiated with a midline dural incision over the dorsal surface
of the spinal cord, followed by lateral dural sutures. Then, an
incision was performed through the arachnoid and pia mater,Table 1 – Modified McCormick scale [5].
Grade Modiﬁed McCormick scale
I Intact neurologically, normal ambulation, minimal
dysesthesia
II Mild motor or sensory deﬁcit, functional independence
III Moderate deﬁcit, limitation of function, independent
w/external aid
IV Severe motor or sensory deﬁcit, limited function,
dependent
V Paraplegia or quadriplegia, sometimes w/ﬂickering
movementat a location that depended upon the location of the most
superﬁcial part of the tumor (n = 6 midline incisions and n = 6
non-midline incisions). When the tumor was identiﬁed, the
arterial feeders were gently coagulated during dissection. The
tumor was microsurgically detached from the surrounding
tissue, shrunken with bipolar coagulation at low power, and
removed en bloc in all cases. It was not necessary to employ an
ultrasound aspirator or laser. Concomitant intramedullary
syrinxes were not directly dissected. The dura was closed in a
watertight fashion. Laminoplasty was not applied. The wound
was closed in a standard fashion. Motor and somatosensory
evoked potentials were monitored during all procedures.
Preoperative embolization was not used.
2.4. Statistical analysis
Fisher's exact test was used to evaluate signiﬁcance. A p-value
<0.05 was taken as statistically signiﬁcant. Also, p-values
between 0.06 and 0.07 were deﬁned as a trend (Figs. 1 and 2).
3. Results
3.1. Patients and symptoms
We analyzed data for ﬁve men (42%) and seven women (58%),
ages 18–59 years (mean 34 years). Six patients (50%) had sIH
Table 2 – Neurological status on postoperative day one, relative to the preoperative condition.











Grade I 6 1 1 0 0
Grade II 0 1 2 0 0
Grade III 0 0 1 0 0
Grade IV 0 0 0 0 0
Grade V 0 0 0 0 0
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 3 4 9 – 3 5 5 351(mean age 22 years; 2 men, 4 women), and 6 patients had vHLS-
IH (mean age 46 years; 3 men, 3 women).
Ambulatory status was classiﬁed as grade I (n = 8), grade II
(n = 3), and grade III (n = 1), according to the preoperative mMS.
Four (33%) patients presented with neurological deﬁcits; three
had progressive single limb paresis; and one had a sensory
deﬁcit. Eight patients were neurologically intact before
surgery; of these, ﬁve had vHLS-IH. Only one patient with
vHLS-IH presented with a neurological deﬁcit. In four cases,
previously diagnosed vHLS was the indication for a diagnostic
evaluation that led to the discovery of an intramedullary
tumor.
Patients with associated syringomyelia had the following
preoperative neurological status: mMS grade I (n = 4; 50%),
grade II (n = 3; 37.5%), grade III (n = 1; 12.5%). All patients
without syrinxes (n = 4) were neurologically intact (mMS
grade I).
3.2. Tumors
Hemangioblastomas accounted for 20% of all intramedullary
tumors (12/60) found in our Department during the study
period.
The tumor sizes varied substantially. Tumors spanned one
spinal segment in 5 patients (42%), two segments in two
patients (17%), three segments in three patients (25%), 4
segments in one patient (8%), and six segments in one patient
(8%). The mean tumor length was 2.3 vertebral segments.
The tumor was located in the cervical spinal cord in 6
patients (50%), at the cervico-thoracic junction in 2 patients
(17%), and in the thoracic region in 4 patients (33%).
Intramedullary syrinxes accompanied the tumor in eight
cases (67%). In six cases, the syrinx extended above the tumor;
in two cases, tumors were located in the upper cervical spine,
and the syrinx was located below the tumor.
Total resection of the tumor was achieved in all cases.
3.3. Neuromonitoring
Every patient underwent intraoperative neurophysiological
monitoring performed with an ISIS IOM System (Inomed). The
corticospinal tract was assessed with motor evoked potentials,
elicited with a transcranial, constant current, electrical
stimulation, delivered in a 5-train sequence. Motor evoked
potentials were recorded with subdermal needle, monopolar
electrodes inserted into the thenar, tibialis anterior, and
abductor halucis muscles, bilaterally. The sensory tract was
assessed with somatosensory evoked potentials, elicited by
stimulating the medial and tibial nerves, bilaterally.No signiﬁcant changes in intraoperative neurophysiologi-
cal recordings were noted for 11 patients. In one case, a
signiﬁcant change was observed in the intraopertive neuro-
physiological recording. In that case, the somatosensory
evoked potential amplitude dropped by 60%, compared to
the baseline neurophysiological recording obtained before the
dural incision. This drop was correlated with a worsening
postoperative clinical status.
3.4. Neuroprotection
An intravenous infusion of methylprednisolone was started
routinely on the day of surgery. After the bolus, continuous
infusion was performed for 24 h (n = 4) or for 48 h (n = 3). For
the patient with the signiﬁcant drop in intraoperative
potential and the subsequent postopertive deﬁcit, the infusion
was prolonged for 96 h. The average infusion time was 46 h.
There were no complications involving steroid administration
in our series.
3.5. Neurological status evaluations
3.5.1. Neurological status postsurgery
Immediately after surgery, compared to the preoperative
status, neurological status remained stable in eight (67%)
patients and worsened in four (33%) patients. Among the eight
patients with stable neurological status, three patients
(37.5%) had asymptomatic vHLS-IH, and ﬁve patients
(62.5%) had sIH, Among the four patients with worsened
neurological status, three (50%) had vHLS-IH, and only one
(17%) had sIH (Table 5).
On postoperative day 1, neurological status was graded
according to the mMS (Table 2).
3.5.2. Neurological status on the day of discharge
Compared to postoperative day 1, at discharge, one patient
had regressed from paraparesis (mMS grade III to grade II). All
other patients remained stable. These mMS grades were
considered early outcome (Table 3).
3.5.3. Neurological status at follow up
Compared to the early outcome, at follow up, neurological
status improved in six patients (50%), and it remained
unchanged in six patients (50%). All but one patient (n = 11;
92%) achieved mMS grade I. One patient (8%) was classiﬁed as
mMS grade II at the last check-up, but died 10 months after the
surgery. The cause of death was unrelated to the intrame-
dullary tumor. The long-term results in relation to preopera-
tive status are shown in Table 4.
Table 3 – Early postoperative outcome. Neurological
status on the day of discharge, relative to the preoperative
condition.







Grade I 6 1 1
Grade II 0 2 1
Grade III 0 0 1
Grade IV 0 0 0
Grade V 0 0 0
Table 4 – Long-term neurological status, relative to the
preoperative status.







Grade I 8 0 0
Grade II 3 0 0
Grade III 0 1a 0
Grade IV 0 0 0
Grade V 0 0 0
a One patient died in the period of neurological deficit regression,
due to esophageal cancer. He was classified as McCormick grade II
in the last evaluation.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 3 4 9 – 3 5 53523.6. Outcome
Postoperative complications included one case of a CSF leak. It
was treated successfully with lumbar drainage. This wound
healed correctly, based on long-term observations. Among all
12 patients, no tumor recurrence was diagnosed during the
mean follow-up period of 5 years. There were no statistical
differences in the early and late outcomes between the sIH and
vHLS-IH groups (Tables 6 and 7).
3.6.1. Sporadic hemangioblastomas
Among patients with sIH, on postoperative day one, three were
classiﬁed as mMS grade I, one as grade II, and two as grade III.
At follow up, neurological status improved in three patients




Postoperative day one 0 3 
Follow up 3 3 
Table 6 – Analysis of factors that might influence the short-ter
Factor Neurological status on
(McCormick c
Grade I 
Age <35 4 (57%) 
Age ≥35 2 (40%) 
Female sex 4 (57%) 
Male sex 2 (40%) 
Preoperative deﬁcit /+/ 0 (0%) 
Preoperative deﬁcit // 6 (75%) 
Spinal levels ≤2 4 (57%) 
Spinal levels >2 2 (40%) 
Syrinx /+/ 3 (37.5%) 
Syrinx // 3 (75%) 
Sporadic 3 (50%) 
vHLS-related 3 (50%) 
NS: no signiﬁcant difference between subgroups.of the six patients, ﬁve achieved mMS grade I and one achieved
mMS grade II.
3.6.2. vHLS-related hemangioblastomas
Among patients with vHLS-IH, on postoperative day one, three
were classiﬁed as mMS grade I, one as mMS grade II, and two as
mMS grade III. At follow up, three patients with postoperative
neurological deﬁcits improved (Table 5), and all patients
reached mMS grade I.
3.6.3. Syrinxes
Among eight patients with associated syrinxes, the neurologi-
cal status on postoperative day 1 was as follows: mMS grade I
(n = 3), mMS grade II (n = 1), and mMS grade III (n = 4). All thesepared to preoperative status in subgroups of patients with
sIH
ioration Improvement Stable Deterioration
3 0 5 1
0 3 3 0
m outcome of surgical tumor excision.






















Grade I Grades II–III
Age <35 7 (100%) 0 (0%) NS
Age ≥35 4 (80%) 1 (20%)
Female sex 7 (100%) 0 (0%) NS
Male sex 4 (80%) 1 (20%)
Preoperative deﬁcit /+/ 3 (75%) 1 (25%) NS
Preoperative deﬁcit // 8 (100%) 0 (0%)
Spinal levels ≤2 7 (100%) 0 (0%) NS
Spinal levels >2 4 (80%) 1 (20%)
Syrinx /+/ 7 (87.5%) 1 (12.5%) NS
Syrinx // 4 (100%) 0 (0%)
Sporadic 5 (83%) 1 (17%) NS
vHLS-related 6 (100%) 0 (0%)
NS: no signiﬁcant difference between subgroups.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 3 4 9 – 3 5 5 353patients showed improved conditions at follow-up; seven
patients reached mMS grade I and one mMS grade II. Of the
four patients without intramedullary syrinxes, three were
assessed as mMS grade I, and one as mMS grade II, on
postoperative day 1. At follow-up, all achieved mMS grade I.
There were no signiﬁcant differences in outcomes between
patients with and without coexisting intramedullary syrinxes
(Tables 6 and 7).
3.7. Factors correlated with outcome
The early postoperative results were not signiﬁcantly different
between subgroups of patients with differences in age, sex,
tumor size, syrinx presence, or vHLS presence. Nevertheless,
we found a trend toward more favorable results among
patients that were neurologically intact before treatment
compared to those with preoperative neurological deﬁcits
(p = 0.06, Table 6). The long-term treatment results were
favorable for all patients. Consequently, we found no statisti-
cally signiﬁcant differences between subgroups of patients
(Table 7). The long-term results did not depend signiﬁcantly on
preoperative neurological status; however, the only patient
with a sustained deﬁcit (mMS grade II) at follow-up, had
presented with paraparesis before surgery (mMS grade III).
4. Discussion
There is no generally accepted strategy for treating asymp-
tomatic intramedullary hemangioblastomas in recent litera-
ture [6–11]. In particular, it can be difﬁcult to decide whether to
perform consecutive resections to remove multiple tumors in
patients with vHLS. Because a preoperative neurological deﬁcit
is often irreversible [6], we decided to resect all tumors,
including those accidentally discovered.
In the series described by Ammerman [7], 5 years of
observation showed that 90% of tumors larger than 4.7 mm in
diameter became symptomatic and required treatment. In the
same study, after 10 years of observation, they found that 98%of hemangioblastomas were symptomatic. In our cohort, all
tumors had main diameters greater than 5 mm. Therefore, we
decided to start treatment shortly after diagnosis.
Recent studies have demonstrated that good preoperative
status is crucial for satisfactory outcome [6,8,11]. Samii and
Klekamp [6] showed that the most important determinant in
long-term outcome was the preoperative level of neurological
function. Ammerman et al. [8] stated that treating hemangio-
blastomas before the appearance of neurological symptoms
resulted in improved neurological outcomes. Van Velthoven
et al. [11] noted that surgical morbidity could be eliminated
only when surgery was performed before signiﬁcant disability
occurred. Only one patient in our group had a signiﬁcant
neurological deﬁcit (McCormick grade III) before surgery. The
majority of our patients had mild neurological symptoms or
asymptomatic tumors. The good postoperative treatment
results conﬁrmed that our decision to perform immediate
surgery was justiﬁed.
The goal of surgery is complete tumor removal. The extent
of resection is an important factor in the outcome [7,9,11].
Roonprapunt [7] stated that incomplete tumor removal might
result in signiﬁcant morbidity and mortality. Mehta [9]
suggested that, because incomplete resection of a hemangio-
blastoma always results in recurrence, tumors should always
be radically removed.
In the present study, 10 cases (83.3%) had tumors that
occupied less than 4 spinal segments. Although tumor size
is not generally recognized as a good prognostic factor
for intramedullary hemangioblastomas, it is possible that a
small size may favor good treatment results. Four
patients without neurological deﬁcits before treatment
had tumors that occupied only one spinal segment. These
patients were neurologically intact in the early postopera-
tive period.
Our ﬁndings that syrinxes did not inﬂuence the outcome
were consistent with those reported by Samii and Klekamp [6]
and Van Velthoven et al. [11]. However, Samii and Klekamp
[6] noticed more rapid recovery in patients with intramedul-
lary hemangioblastoma and coexisting syringomyelia. In
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 3 4 9 – 3 5 5354our series, eight patients (67%) had intramedullary hemangio-
blastomas accompanied by syrinxes, but the syrinxes did not
inﬂuence the outcomes.
In our series, vHLS coexisted with intramedullary heman-
gioblastoma in six cases (50%). Recent studies have shown that
only 30% of patients with intramedullary hemangioblastoma
had genetically conﬁrmed vHLS [12,13]. Clark et al. studied a
series that had equal numbers of patients with sIH and vHLS-
IH [14]. Because the operative treatment results were similarly
satisfactory in both groups, the coexistence of vHLS had no
signiﬁcant inﬂuence on outcome.
Our long-term results were satisfactory in all patients.
Therefore, we found no signiﬁcant correlations between the
follow up results and sex, age, tumor location, or symptom
duration. Nevertheless, in the early postoperative period, we
found a trend toward a better outcome among patients that
were neurologically intact before treatment. Moreover, Brotchi
found that, in over 90% of cases, those with moderate
neurological deﬁcits before surgery displayed good treatment
results [15]. Our results also suggested that surgical risk was
related to the neurological condition before surgery.
The results obtained in our patients with vHLS conﬁrmed
the rationale for early treatment. For multiple vHLS-related
tumors, the surgical treatment removed all large (space-
occupying) asymptomatic lesions. Nevertheless, many
authors argue that only a neurological deﬁcit progression
can justify surgery for patients with vHLS [8,9,16–20,4].
Ammerman [8] and Mehta [9] argued that surgical resections
based on radiological progression may lead to many unneces-
sary resections. Huang [16] suggested that only symptomatic
lesions can justify surgical removal, due to the risk of
postoperative neurological deﬁcits. Lonser [18] suggested that,
due to the multiplicity of surgical procedures that are
necessary in patients with vHLS over their lifetime, only
selective removal of symptomatic lesions should be consid-
ered.
The natural history of intramedullary hemangioblastoma
is not precisely known. Thus, decisions about operative
treatment should always consider the risk of a sudden
appearance of a neurological deﬁcit. Due to phases of rapid
tumor progression [4], it is difﬁcult to determine the best time
to surgically remove an asymptomatic lesion. In our series, no
patient exhibited a permanent severe neurological deﬁcit
postsurgery. Therefore, we considered that, in these patients,
the operative risk was low. Similarly, in the series studied by
Van Velthoven et al. [11], no patients deteriorated compared to
preoperative status. In the study by Lonser [18], only 9% of
patients exhibited a worse condition compared to the
preoperative condition. The cohort analyzed by Bostrom [2]
showed outcomes similar to our results. Based on our
outcomes, we concluded that treatment should be considered
for asymptomatic tumors that are surgically accessible and
exhibit a mass effect.
In patients with vHLS and multiple intramedullary tumors,
the determining factor for commencing treatment should be
radiologically documented tumor progression, not a neuro-
logical manifestation [7,11,16,20]. As Van Velthoven et al.
stated, neurological deﬁcits are often irreversible [11]; there-
fore, it seems unreasonable to wait for their appearance.
Lonser suggested that patients with vHLS merit life-longobservation to detect tumor progression before neurological
deﬁcits appear [18]. In particular, the radiologically documen-
ted growth of a peritumoral cyst is dangerous and requires
surgical removal, in the opinion of Weil [20]. Thus, the
favorable results we found with the surgical removal of
asymptomatic intramedullary hemangioblastomas in both sIH
and vHLS-IH supported the notion that modern treatment
should adopt a more aggressive attitude. Our policy in
managing small, asymptomatic, vHLS-IH is to perform close
surveillance with serial MRIs each year to detect any
signiﬁcant tumor progression before a clinical presentation.
5. Conclusions
This study showed that the surgical removal of IH resulted in
satisfactory long-term functional outcomes. Moreover, opera-
tive treatments were similarly favorable for both sIH and
vHLS-IH lesions. We recommend that surgery should be
considered for managing asymptomatic, surgically accessible,
space-occupying lesions in sIH group, and isolated, space-
occupying lesions in vHLS-IH group, because the best results
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